Clinical Trials Directory

Trials / Unknown

UnknownNCT02082054

StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study

A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
125 (estimated)
Sponsor
Magna Pharmaceuticals, Inc. · Industry
Sex
All
Age
12 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This active vs active comparative trial will evaluate the safety and efficacy of incremental doses of atropine in combination with pseudoephedrine 120 mg/chlorpheniramine 8 mg in adult patients with a history of seasonal allergic rhinitis. Hypotheses are defined by total nasal symptom scores (TNSS) recorded by subjects in diaries where efficacy will be established by statistical significance where p \< 0.05.

Detailed description

Actives in each of the five study arms: Pseudoephedrine 120 mg/Chlorpheniramine 8 mg/Atropine 0.36 mg Pseudoephedrine 120 mg/Chlorpheniramine 8 mg/Atropine 0.24 mg Pseudoephedrine 120 mg/Chlorpheniramine 8 mg/Atropine 0.12 mg Pseudoephedrine 120 mg/Chlorpheniramine 8 mg Atropine 0.24 mg

Conditions

Interventions

TypeNameDescription
DRUGPSE 120 mg, CM 8 mg, Atr 0.36 mgPseudoephedrine 120 mg, chlorpheniramine 8 mg, atropine 0.36 mg white, scored, tablets with "M27" on scored side and plain on the other side
DRUGPSE 120 mg, CM 8 mg, Atr 0.24 mgPseudoephedrine 120 mg, chlorpheniramine 8 mg, atropine 0.24 mg white, scored, tablets with "M27" on scored side and plain on the other side
DRUGPSE 120 mg, CM 8 mg, Atr 0.12 mgPseudoephedrine 120 mg, chlorpheniramine 8 mg, atropine 0.12 mg white, scored, tablets with "M27" on scored side and plain on the other side
DRUGPSE 120 mg, CM 8 mgPseudoephedrine 120 mg, chlorpheniramine 8 mg tablets dosed BID
DRUGAtropine 0.24 mgAtropine sulfate 0.24 mg white, scored, tablets with "M27" on scored side and plain on the other side

Timeline

Start date
2014-03-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2014-03-10
Last updated
2014-05-30

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02082054. Inclusion in this directory is not an endorsement.